Ritsuko Iwanaga

14PUBLICATIONS
45CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersHaematological tumoursOrganised crime
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 19, 2026
Inhibiting CXCR2 Remodels the Tumor Microenvironment and Blunts Tumor Progression and Dissemination of High-Grade Serous Carcinoma.

|Jan 24, 2026
Chromobox 2 Inhibition: A Novel Activity of Alisertib, an Aurora A Kinase Inhibitor.

Tomomi M Yamamoto, Ritsuko Iwanaga, Elizabeth R Woodruff

|Jan 09, 2026
Distinct Regulation of the ARF and TAp73 Tumor Suppressor Genes by the Transcription Factor E2F1 Enables Discrimination of Cancer Cells from Normal Growing Cells.

Yaxuan Zhou, Rinka Nakajima, Mashiro Shirasawa

|Dec 24, 2025
Utility of Tumor Suppressor E2F Target Gene Promoter Elements to Drive Gene Expression Specifically in Cancer Cells.

Kenta Kurayoshi, Masakazu Tanaka, Rinka Nakajima

|Oct 29, 2025
Transcriptional Activation Mechanisms and Target Genes of the Oncogene Product Tax of Human T-Cell Leukemia Virus Type 1.

Mashiro Shirasawa, Rinka Nakajima, Yaxuan Zhou

|Aug 28, 2025
The Transcriptional Coactivator DEAD/H Box 5 (DDX5) Gene Is a Target of the Transcription Factor E2F1 Deregulated from the Tumor Suppressor pRB.

Rinka Nakajima, Yaxuan Zhou, Mashiro Shirasawa

Pageof 3

Frequent Collaborators

8 joint publications

Andrew P Bradford

8 joint publications

Rinka Nakajima

7 joint publications

Yaxuan Zhou

6 joint publications

Elizabeth R Woodruff